Souheil Moussly
Internal Medicine · Port Orange, FLNPI 1063524577
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AstraZeneca at 31.6% of the total. Reporting peaked in 2019 at $915 and has fallen 80.5% since, to $178 in 2022.
Across 112 payments — averaging $15.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$565
- Novo Nordisk$210
- GSK$200
- Lilly USA, LLC$166
- Boehringer Ingelheim$133
- Amgen$122
- plus $391 from 11 others
Across 31 payments — averaging $8022.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$227K
- Vifor (international) Ltd.$22K
What the payments were for
- Food & beverage$1,781100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 31 | $565 |
| Novo Nordisk | 15 | $210 |
| GSK | 10 | $200 |
| Lilly USA, LLC | 11 | $166 |
| Boehringer Ingelheim | 10 | $133 |
| Amgen | 8 | $122 |
| Amarin Pharma, Inc. | 5 | $79 |
| AbbVie | 4 | $75 |
| Merck | 5 | $68 |
| Pfizer | 3 | $43 |
| Abbott | 3 | $39 |
| Johnson & Johnson | 2 | $25 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Astellas Pharma US Inc | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
| Nalpropion Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$125
- TRELEGY ELLIPTA$111
How this compares
$1,787 in reported general payments places this provider in the 75th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Port Orange
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.